Evaluation of the Use of RELAX Glasses on Anxiety of Patients Undergoing Dental Extraction > 2 Teeth, Under Local Anesthesia, Compared With Those Not Using Glasses
BRIGAND
1 other identifier
interventional
106
1 country
1
Brief Summary
The vast majority of tooth extraction surgery is performed under local anaesthetic, and can be a source of anxiety. In their 2015 article, Appukuttan et al studied the anxiety felt by 1148 patients prior to tooth extraction, and reported up to 82% of patients anxious before a procedure. In 2020, Yamashita et al demonstrated the value of virtual reality in reducing patient anxiety during the extraction of three impacted mandibular molars, with no clear effect on the pain felt by the patient. The use of a virtual reality headset has been shown to reduce anxiety in dental surgery or in hand surgery under local anesthesia with the WALANT technique. On the other hand, virtual reality and the use of 3D can cause discomfort and side effects such as nausea and dizziness. Audiovisual distraction is also known to be effective in reducing pain and anxiety in patients, with fewer side effects. The investigators have therefore chosen to use RELAX® eyewear. They wish to study its effect on anxiety, pain and overall patient and surgeon satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable surgery
Started Aug 2023
Shorter than P25 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2024
CompletedFirst Submitted
Initial submission to the registry
September 6, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedJuly 2, 2025
September 1, 2024
11 months
September 6, 2024
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in visual analogue scale anxiety scores after tooth extraction
The visual analogue anxiety scale from 0 to 10, with meaning no anxiety and 10 very high anxiety
In the 5 minutes after the end of surgery
Secondary Outcomes (6)
Overall satisfaction between the group using RELAX glasses and the group following the usual course (without RELAX glasses) measured by a visual analogue scale
Immediative postoperative
Variation in pain between entering and leaving the surgical technical platform between the 2 arms using a visual analogue scale
In the 5 minutes after the end of surgery
Rate of patients receiving at least one analgesic
After local anesthesia
Surgeon's satisfaction with the feasibility of the procedure in a patient wearing RELAX glasses filling in a self-assessment questionnaire
Immediative postoperative
Pre-existing anxiety, only in patients receiving RELAX glasses, measured with the STAI-YB score
7 days (+/-3 days) after surgery
- +1 more secondary outcomes
Study Arms (2)
Group with RELAX glasses
EXPERIMENTALBehavioral : RELAX glasses Glasses which are a solution of audiovisual sedation by positive distraction for hospital medical use
Group without RELAX glasses
NO INTERVENTIONInterventions
Glasses which are a solution of audiovisual sedation by positiv distraction for hospital medical use
Eligibility Criteria
You may qualify if:
- Patient undergoing dental extraction \> 2 teeth under local anesthesia;
- Patient with written consent or additional parental consent for minors;
- Socially insured patient;
- Patient willing to comply with all study procedures and duration.
You may not qualify if:
- Medical history contraindicating RELAX glasses
- Known and current abuse of alcohol and/or illicit drugs that may interfere with patient safety and/or compliance;
- Any condition that would render the patient unfit for the study: current presence of cognitive disorders (MMS \< 15), severe psychiatric disorders (bipolar disorders, psychotic disorders according to DSM-V classification);
- Major anxiety requiring preoperative anxiolytics;
- Patient under court protection;
- Patient participating in another study;
- Patient's refusal to use glasses;
- Visually impaired or blind patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier de Valenciennes
Valenciennes, France, 59300, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2024
First Posted
September 19, 2024
Study Start
August 31, 2023
Primary Completion
July 18, 2024
Study Completion
July 26, 2024
Last Updated
July 2, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share